# Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for Renal Cell Carcinoma

> **NCT02138578** · NA · TERMINATED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 4 (actual)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **RADIATION:** SBRT
- **RADIATION:** RFA

## Key facts

- **NCT ID:** NCT02138578
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-05
- **Primary completion:** 2016-12
- **Final completion:** 2017-02
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Due to changes in scanning procedure, and infeasible biopsy and baseline imaging, the trial closed for poor accrual and inability to follow patients.
- **Last updated:** 2017-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02138578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02138578, "Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for Renal Cell Carcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02138578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*